Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Pentostam

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2004
Highly Cited
2004
Arsenicals and antimonials are first line drugs for the treatment of trypanosomal and leishmanial diseases. To create the active… Expand
Highly Cited
2001
Highly Cited
2001
ABSTRACT In both scid and BALB/c mouse-Leishmania donovani models, hexadecyphosphocholine (miltefosine) and AmBisome had similar… Expand
Highly Cited
2000
Highly Cited
2000
A quantitative colorimetric assay using the oxidation-reduction indicator Alamar Blue was developed to measure cytotoxicity of… Expand
Highly Cited
1995
Highly Cited
1995
Successful treatment in allergic, autoimmune, and infectious diseases often requires altering the nature of a detrimental immune… Expand
  • figure 1
  • figure 3
Review
1992
Review
1992
Pentavalent antimonial compounds have been the mainstay of the treatment of visceral, cutaneous, and mucosal leishmaniasis for… Expand
Highly Cited
1992
Highly Cited
1992
To determine the relative efficacy and toxicity of stibogluconate and ketoconazole for the treatment of cutaneous leishmaniasis… Expand
Highly Cited
1992
Highly Cited
1992
We report that in vitro sensitivity to pentavalent antimony (Sb5) of 35 Leishmania isolates as determined by the semiautomated… Expand
Highly Cited
1989
Highly Cited
1989
Antimony unresponsiveness in mucocutaneous and visceral leishmaniasis is a serious clinical problem. Information on the… Expand
Highly Cited
1989
Highly Cited
1989
We report the characterization of 6 Leishmania tropica isolates from 2 patients with visceral leishmaniasis who were unresponsive… Expand
Review
1988
Review
1988
  • J. Berman
  • Reviews of infectious diseases
  • 1988
  • Corpus ID: 24681317
The 1980s have seen significant advances in the treatment of cutaneous, mucosal, and visceral leishmaniasis. Safe regimens of… Expand